Dr. Sacha Sidjanski, studied biology in Geneva, worked on infectious diseases at the Swiss Tropical Institute (Basel, CH) and at New York University (NYU, USA), followed by two post-doctoral works at SUNY (State University of New York) and at Pasteur Institute (France); he then joined the World Health Organization (WHO) at the end of 1999 as a ‘scientific officer’.

Since June 2006, Dr Sidjanski works as External Relations Manager at the School of Life Sciences at EPFL which is the home of four institutes -the Global Health Institute, the Brain & Mind Institute, -Swiss Institute for Experimental Cancer Research, and the Institute of Bioengineering. The School of Life Sciences has more than a thousand collaborators.

Sacha was also involved in a not-for-profit foundation, Innovative Medicines for Tuberculosis (iM4TB) pro bono based in the Innovation Park on the EPFL campus.

In 2016, Sacha and a team received the Challenge Debiopharm-Inartis for an innovative project, the Hello Mask Project, in the field of healthcare targeting physical and moral comfort of patients.

Born on 20 July 1964 in Geneva, Christophe holds a degree in commercial and industrial sciences, with a specialization in business management, University of Geneva, 1989.

Senior Auditor from 1991 to 1995 at Price Waterhouse Geneva, he joined Cartier / High Jewelry House as CFO/COO until 2008. In 2009, he became head of the High Jewelry division at Chopard.

In 2011 Christophe became CEO of Genève-Servette Hockey Club (GSHC), which he left in 2016 leaving a club with solid financial foundations.

After a mandate as Secretary General in a Swiss private bank, Christophe was recalled to the management of the GSHC in 2018 for 2 years, before taking the general management of a company specializing in ecofriendly construction for nearly three years. He moved from that position to a role of CEO and shareholder of a development company involved in sport infrastructure and real estate development in Valais.

In addition to his involvement in the HM Care project, Christophe currently holds various mandates and sits on several boards of directors.

For 10 years, he held various senior positions as Director and global Vice-President of Research and Development with US companies, including California-based DJO Inc. In 2009, he left the industry to create the EssentialMed Foundation, which aims to make access to medical technology universal by developing and deploying high quality, affordable devices for the developing world. In 2011, Klaus joined the EPFL to initiate and lead EssentialTech, a programme with the same goal, which expanded to more technology domains.

​